Results
89
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
89 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.38 | -7.4% | 4.9% | SEK 374.2m | SEK 2.20 | PS4.1x | E90.4% | n/a | Tech | ||
CALTX | SEK 206.20 | -0.2% | 106.7% | SEK 11.1b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 240.00 | -10.8% | 139.5% | SEK 20.7b | SEK 267.50 | PE124.8x | E43.8% | n/a | Software | ||
MAGLE | SEK 39.00 | -7.1% | 12.7% | SEK 421.2m | SEK 50.00 | PE54.7x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
CTT | SEK 264.00 | -4.0% | 22.2% | SEK 3.3b | n/a | PE32.5x | E24.8% | 2.0% | Capital Goods | ||
YIELD | SEK 2.34 | -1.3% | -67.0% | SEK 134.0m | SEK 9.00 | PB1.6x | E103.4% | n/a | Diversified Financials | ||
BIOA B | SEK 148.10 | -2.9% | -52.7% | SEK 13.1b | SEK 326.40 | PS51.9x | E104.2% | 0% | Pharmaceuticals & Biotech | ||
EDYOU | SEK 1.15 | -15.2% | 3.1% | SEK 46.6m | n/a | PS1.4x | E63.1% | n/a | Media | ||
BIOVIC B | SEK 2.65 | -10.5% | -71.1% | SEK 222.7m | SEK 7.90 | PS30.5x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.21 | -6.4% | -29.2% | SEK 239.0m | SEK 3.65 | PS2.5x | E104.9% | n/a | Tech | ||
CRAD B | SEK 41.20 | -5.2% | 42.1% | SEK 1.4b | SEK 57.00 | PE25.9x | E33.9% | n/a | Healthcare | ||
ORGC | SEK 3.08 | -7.5% | -31.4% | SEK 302.2m | SEK 3.00 | PS2.2x | E109.0% | n/a | Materials | ||
FLEXQ | SEK 10.20 | -7.3% | -62.2% | SEK 136.7m | SEK 25.00 | PS1.1x | E111.9% | n/a | Capital Goods | ||
CTM | SEK 6.10 | -13.5% | -74.0% | SEK 461.5m | SEK 29.70 | PB0.2x | E115.4% | 0% | Media | ||
KLAR | SEK 0.31 | -1.9% | -49.8% | SEK 40.2m | SEK 1.00 | PB1.4x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
EQT | SEK 300.00 | -12.0% | 26.0% | SEK 354.7b | SEK 360.17 | PE102.1x | E56.9% | 1.2% | Diversified Financials | ||
MIDS | SEK 1.22 | -12.6% | -49.0% | SEK 256.7m | SEK 2.80 | PS4x | E89.9% | n/a | Semiconductors | ||
SENZA | SEK 6.95 | -2.1% | -30.2% | SEK 205.1m | SEK 16.50 | PS3.9x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
4C | SEK 20.40 | 2.0% | -21.5% | SEK 716.7m | SEK 22.00 | PS2.4x | E108.0% | n/a | Software | ||
TRUE B | SEK 31.96 | -5.7% | -15.9% | SEK 11.0b | SEK 54.83 | PE23.1x | E21.5% | 1.3% | Software | ||
NIUTEC | SEK 5.96 | -9.7% | -45.7% | SEK 121.4m | SEK 9.50 | PB1.5x | E94.1% | n/a | Capital Goods | ||
FNOX | SEK 59.58 | -10.5% | -3.2% | SEK 36.3b | SEK 73.00 | PE55.9x | E22.6% | 0.3% | Software | ||
EGTX | SEK 5.55 | -7.8% | 26.1% | SEK 1.6b | SEK 13.30 | PS25.8x | E98.6% | n/a | Pharmaceuticals & Biotech | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods |